| The global impact of SARS-CoV-2 in 181 people with cystic fibrosis E McClenaghan, R Cosgriff, K Brownlee, S Ahern, PR Burgel, CA Byrnes, ... Journal of cystic fibrosis 19 (6), 868-871, 2020 | 109 | 2020 |
| Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020 L Naehrlich, A Orenti, F Dunlevy, I Kasmi, S Harutyunyan, A Pfleger, ... Journal of cystic fibrosis 20 (4), 566-577, 2021 | 60 | 2021 |
| Epidemiology of nontuberculous mycobacteria infection in children and young people with cystic fibrosis: analysis of UK cystic fibrosis registry AI Gardner, E McClenaghan, G Saint, PS McNamara, M Brodlie, ... Clinical Infectious Diseases 68 (5), 731-737, 2019 | 51 | 2019 |
| Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study SB Carr, E McClenaghan, A Elbert, A Faro, R Cosgriff, O Abdrakhmanov, ... Journal of Cystic Fibrosis 21 (4), e221-e231, 2022 | 26 | 2022 |
| UK Cystic Fibrosis Registry Annual Data Report 2018 S Charman, E McClenaghan, R Cosgriff, A Lee, S Carr Cystic Fibrosis Trust, London, United Kingdom.[Google Scholar], 2019 | 15 | 2019 |
| COVID-19 vaccine prioritisation for people with cystic fibrosis SB Carr, R Cosgriff, S Harutyunyan, PG Middleton, R Ruseckaite, S Ahern, ... Journal of Cystic Fibrosis 20 (4), 715-716, 2021 | 11 | 2021 |
| National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study … AA Powell, G Ireland, R Leeson, A Lacey, B Ford, J Poh, S Ijaz, J Shute, ... Journal of Infection 86 (4), 361-368, 2023 | 9 | 2023 |
| What predicts hospital admissions in community-dwelling people with parkinsonism? R Sebastian, WK Gray, A Foley, L Trendall, D Oh, A Hand, S Dodds, ... Journal of geriatric psychiatry and neurology 33 (2), 103-108, 2020 | 6 | 2020 |
| UK Cystic Fibrosis Registry Annual data report 2018 2019 S Charman, E McClenaghan, R Cosgriff, A Lee, S Carr August, 2021 | 4 | 2021 |
| Global Registry Harmonization Group, et al E McClenaghan, R Cosgriff, K Brownlee, S Ahern, PR Burgel, CA Byrnes, ... The global impact of SARS-CoV-2 in 181, 868-871, 0 | 4 | |
| COVID-19 infections in English schools and the households of students and staff 2020–21: a self-controlled case-series analysis E McClenaghan, P Nguipdop-Djomo, A Lewin, C Warren-Gash, S Cook, ... International Journal of Epidemiology 53 (4), dyae105, 2024 | | 2024 |
| P131 Effect of deprescribing from inhaled corticosteroids in people with cystic fibrosis: challenges & opportunities for a target trial emulation using the UK CF Registry E McClenaghan, R Keogh, G Davies, J Rouette, J Tazare Journal of Cystic Fibrosis 23, S125, 2024 | | 2024 |
| Acute and long-term outcomes of SARS-CoV-2 infection in school-aged children in England: Study protocol for the joint analysis of the COVID-19 schools infection survey (SIS … KJ Looker, E McClenaghan, A Judd, L Pierotti, H Downing, J Phelan, ... Plos one 19 (5), e0303892, 2024 | | 2024 |
| The association between SARS-CoV-2 infections in English primary and secondary school children and staff, and infections in members of their household in the schoolyear 2020 … E McClenaghan, P Nguipdop-Djomo, A Lewin, C Warren-Gash, S Cook, ... medRxiv, 2023.11. 27.23299066, 2023 | | 2023 |
| CHANGES IN SARS-COV-2 ANTIBODY PREVALENCE IN PRIMARY AND SECONDARY SCHOOLS STUDENTS DURING THE EMERGENCE OF THE OMICRON VARIANT: THE UK SCHOOLS INFECTION SURVEYS P Nguipdop-Djomo, A Lacey, J Poh, G Ireland, E McClenaghan, P Jones, ... International Journal of Infectious Diseases 130, S132, 2023 | | 2023 |
| P083 Clinical progression of SARS-CoV-2 infection in people with cystic fibrosis: a global observational study E McClenaghan, R Cosgriff, K Brownlee, S Ahern, PR Burgel, CA Byrnes, ... Journal of Cystic Fibrosis 20, S65, 2021 | | 2021 |
| WS13. 5 Access to treatments for people with cystic fibrosis across Europe: a 6-country pilot survey E McClenaghan, T Speight, K Earlam, N Medhurst, SC Charman, ... Journal of Cystic Fibrosis 19, S22-S23, 2020 | | 2020 |
| P068 Describing treatment burden in people with cystic fibrosis: analysis of the UK Cystic Fibrosis Registry A Lee, E McClenaghan, SC Charman, SB Carr Journal of Cystic Fibrosis 18, S76-S77, 2019 | | 2019 |
| P085 Investigating time between annual review encounters in the UK Cystic Fibrosis Registry E McClenaghan, R Cosgriff, M Yip, SC Charman, A Lee, E Gunn, ... Journal of Cystic Fibrosis 18, S81-S82, 2019 | | 2019 |
| WS02. 1 Epidemiology of nontuberculous mycobacteria infection in children and young people with cystic fibrosis: analysis of United Kingdom Cystic Fibrosis Trust Registry data M Brodlie, AI Gardner, E Mcclenaghan, GL Saint, PS Mcnamara, ... Journal of Cystic Fibrosis 17, S3, 2018 | | 2018 |
